ABCL
Price
$3.62
Change
-$0.35 (-8.82%)
Updated
Nov 13, 04:59 PM (EDT)
Capitalization
1.08B
102 days until earnings call
Intraday BUY SELL Signals
LCTX
Price
$1.80
Change
-$0.13 (-6.74%)
Updated
Nov 13 closing price
Capitalization
414.59M
111 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

ABCL vs LCTX

Header iconABCL vs LCTX Comparison
Open Charts ABCL vs LCTXBanner chart's image
AbCellera Biologics
Price$3.62
Change-$0.35 (-8.82%)
Volume$71.39K
Capitalization1.08B
Lineage Cell Therapeutics
Price$1.80
Change-$0.13 (-6.74%)
Volume$1.62M
Capitalization414.59M
ABCL vs LCTX Comparison Chart in %
View a ticker or compare two or three
VS
ABCL vs. LCTX commentary
Nov 14, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABCL is a Hold and LCTX is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Nov 14, 2025
Stock price -- (ABCL: $3.97 vs. LCTX: $1.93)
Brand notoriety: ABCL and LCTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABCL: 53% vs. LCTX: 764%
Market capitalization -- ABCL: $1.08B vs. LCTX: $414.59M
ABCL [@Biotechnology] is valued at $1.08B. LCTX’s [@Biotechnology] market capitalization is $414.59M. The market cap for tickers in the [@Biotechnology] industry ranges from $110.25B to $0. The average market capitalization across the [@Biotechnology] industry is $2.1B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABCL’s FA Score shows that 0 FA rating(s) are green whileLCTX’s FA Score has 0 green FA rating(s).

  • ABCL’s FA Score: 0 green, 5 red.
  • LCTX’s FA Score: 0 green, 5 red.
According to our system of comparison, both ABCL and LCTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABCL’s TA Score shows that 3 TA indicator(s) are bullish while LCTX’s TA Score has 3 bullish TA indicator(s).

  • ABCL’s TA Score: 3 bullish, 6 bearish.
  • LCTX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, LCTX is a better buy in the short-term than ABCL.

Price Growth

ABCL (@Biotechnology) experienced а -15.35% price change this week, while LCTX (@Biotechnology) price change was +6.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.51%. For the same industry, the average monthly price growth was -3.12%, and the average quarterly price growth was +61.90%.

Reported Earning Dates

ABCL is expected to report earnings on Feb 24, 2026.

LCTX is expected to report earnings on Mar 05, 2026.

Industries' Descriptions

@Biotechnology (+1.51% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ABCL($1.08B) has a higher market cap than LCTX($415M). LCTX YTD gains are higher at: 284.080 vs. ABCL (35.495). LCTX has higher annual earnings (EBITDA): -19.77M vs. ABCL (-197.92M). ABCL has more cash in the bank: 553M vs. LCTX (42.3M). LCTX has less debt than ABCL: LCTX (2.15M) vs ABCL (142M). ABCL has higher revenues than LCTX: ABCL (32.9M) vs LCTX (10.9M).
ABCLLCTXABCL / LCTX
Capitalization1.08B415M261%
EBITDA-197.92M-19.77M1,001%
Gain YTD35.495284.08012%
P/E RatioN/AN/A-
Revenue32.9M10.9M302%
Total Cash553M42.3M1,307%
Total Debt142M2.15M6,592%
FUNDAMENTALS RATINGS
LCTX: Fundamental Ratings
LCTX
OUTLOOK RATING
1..100
24
VALUATION
overvalued / fair valued / undervalued
1..100
68
Overvalued
PROFIT vs RISK RATING
1..100
81
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
35
P/E GROWTH RATING
1..100
52
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
ABCLLCTX
RSI
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
90%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
81%
Bearish Trend 2 days ago
86%
Momentum
ODDS (%)
Bearish Trend 2 days ago
84%
Bullish Trend 2 days ago
80%
MACD
ODDS (%)
Bearish Trend 2 days ago
86%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
82%
Advances
ODDS (%)
N/A
Bullish Trend 2 days ago
78%
Declines
ODDS (%)
Bearish Trend 2 days ago
85%
Bearish Trend 25 days ago
81%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
74%
Bearish Trend 2 days ago
82%
Aroon
ODDS (%)
Bearish Trend 2 days ago
86%
Bullish Trend 2 days ago
84%
View a ticker or compare two or three
Interact to see
Advertisement
ABCL
Daily Signal:
Gain/Loss:
LCTX
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
MYIIX10.450.06
+0.58%
NYLI WMC International Research Eq Cl I
GWGIX19.880.07
+0.35%
AMG GW&K Small Mid Cap Core I
PJFAX69.57-0.09
-0.13%
PGIM Jennison Growth A
NRMGX19.00-0.08
-0.42%
Neuberger Berman Mid Cap Growth R6
AIGYX11.16-0.10
-0.89%
abrdn Real Estate Fund Instl

ABCL and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABCL has been loosely correlated with RXRX. These tickers have moved in lockstep 59% of the time. This A.I.-generated data suggests there is some statistical probability that if ABCL jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABCL
1D Price
Change %
ABCL100%
-1.00%
RXRX - ABCL
59%
Loosely correlated
-1.27%
CRSP - ABCL
59%
Loosely correlated
-5.47%
VCYT - ABCL
56%
Loosely correlated
-0.84%
ABSI - ABCL
55%
Loosely correlated
-1.45%
BEAM - ABCL
52%
Loosely correlated
-2.71%
More

LCTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, LCTX has been loosely correlated with MDGL. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if LCTX jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LCTX
1D Price
Change %
LCTX100%
+6.04%
MDGL - LCTX
43%
Loosely correlated
-2.32%
AXON - LCTX
33%
Loosely correlated
-0.47%
MGNX - LCTX
33%
Poorly correlated
-3.29%
ABCL - LCTX
32%
Poorly correlated
-1.00%
ELVN - LCTX
32%
Poorly correlated
+3.36%
More